Although there is a disconnect in response measures observed in women, i.e., no difference in survival yet better LV reverse remodeling, functional and NT-proBNP response, our findings suggest that women with HFrEF receiving CRT could perhaps be a subgroup in which further studies such as into heart failure medication withdrawal may be considered [28]. This evidence concerns the gene NPPB and heart failure.